Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hologic, Inc.
The VC market during 2021 was frantic, cash rich and oftentimes appeared to be acting on a “buy now, ask questions later” mentality. With COVID headwinds dwindling, and emerging market uncertainties, what will 2022 bring?
2021 was a busy year in the medtech investment space. How will 2022 compare?
Listing all-time high medtech IPO and M&A activity, Silicon Valley Bank’s 2021 health care investments and exits report made good reading after the market uncertainties induced by the pandemic a year earlier. But where does the sector go now after such a sterling year?
Medtech Insight today publishes its latest Top 100 listing of public medical device companies by revenues, and individual rankings for cardiology, orthopedics, IVDs and imaging.
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Acessa Health Inc.
- Biotheranostics, Inc.
- Bolder Surgical, Cytyc Corporation
- Faxitron Bioptics, LLC
- Focal Therapeutics, Inc.
- Gen-Probe Inc.
- Interlace Medical Inc.
- Palomar Medical Techologies
- SuperSonic Imagine
- Third Wave Technologies
- SOMATEX Medical Technologies GmbH